MedPath

Multi-center Clinical Trials of Sanjie Analgesic Capsule in Treating Endometriosis

Phase 4
Conditions
Dysmenorrhea
Interventions
Registration Number
NCT02031523
Lead Sponsor
Jiangsu Kanion Pharmaceutical Co., Ltd
Brief Summary

It is a multi-center, double -blind, placebo -controlled, randomized post-marketing study in Chinese subjects with endometriosis-associated pain to assess treatment effect and safety in the subjects treated with Sanjie Analgesic Capsule versus subjects treated with placebo.

Detailed Description

Sanjie Analgesic Capsule is a Chinese Traditional Patent Medicine. It is a botanical extract from the raw materials of the Resina Draconis , Panax Notoginseng, fritillary bulb and coix seed, which are derived from a classic prescription of traditional Chinese medicine.

Sanjie Analgesic Capsule was approved by CFDA in 2004, produced by means of modern technology by Jiangsu Kanion Pharmaceutical Co., Ltd. The study is a multi-center, double -blind, placebo-controlled, randomized in Chinese subjects with endometriosis-associated pain to assess treatment effect and safety in the subjects treated with Sanjie Analgesic Capsule versus subjects treated with placebo.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
400
Inclusion Criteria
  • Subjects have a diagnosis of endometriosis by laparoscopy within 5 years prior to signing ICF, main complain of dysmenorrhea (or menstrual pain or painful periods) and with VAS score of 4 or above; Endometriosis combined with uterine adenomyosis is included.
  • Female between the ages of 18 and 45 years old;
  • Regular menstrual period, menstrual cycle falls in the ranging from 28 to 30 days;
  • No pregnancy planning during taking study medication; use (or have their partner use) an acceptable method of birth control within the projected duration of the study ;
  • Subjects must sign ICF and agree for follow up.
Exclusion Criteria
  • Genital cancer or other malignant tumor;
  • Adnexal masses≥5cm;
  • Uterine myoma≥3cm;
  • Suffering from cardiovascular, hepatic, renal or hematopoietic system disease or mental illness;
  • Receiving hormone therapy within 3 months prior to signing ICF;
  • Receiving surgical treatment for endometriosis within 3 months prior to signing ICF;
  • Subjects have a plan of pregnancy, being pregnant, breast-feeding during recent 3 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
placeboplaceboevery 4 capsules, 3 times a day, on the first day of menstruation to start taking, taking three consecutive menstrual cycle.
Sanjie analgesic capsuleSanjie analgesic capsuleevery 4 capsules , 3 times a day, on the first day of menstruation to start taking, taking three consecutive menstrual cycle.
Primary Outcome Measures
NameTimeMethod
dysmenorrheaBaseline, 1,2,3,4 menstrual cycle
Secondary Outcome Measures
NameTimeMethod
change of Signs(Pelvic-tenderness Tubercle )baseline,1,2,3,4 menstrual cycle
the size of uterus and endometriosis cystbaseline,3,4 menstrual cycle
change of Menstrual cycle and quantitybaseline,1,2,3,4 menstrual cycle
change of serum CA125baseline,3,4 menstrual cycle
change of SF-36 scoreBaseline,3 menstrual cycle
Safety assessments will be based on electrocardiogram, physical examinations, and clinical laboratory testsBaseline,3 menstrual cycle
change of Symptom (CPP Dyspareunia Defecate-pain Anal-bulge )baseline,1,2,3,4 menstrual cycle
change of serum endocrinological hormonebaseline,3,4 menstrual cycle

the content of FSH, LH, E2, PRL, P, T

Safety assessments will be based on adverse event reports1,2,3 menstrual cycle

Trial Locations

Locations (14)

Beijing ChaoYang Hospital

🇨🇳

Beijing, Beijing, China

The General Hospital of People's Liberation Army

🇨🇳

Beijing, Beijing, China

The Maternal and Child Health Hospital of Hunan Province

🇨🇳

Changsha, Hunan, China

The Second Hospital of Shandong University of Traditional Chinese Medicine

🇨🇳

Jinan, Shandong, China

Women's Hospital School Of Medicine Zhejiang University

🇨🇳

Hangzhou, Zhejiang, China

Jinan municipal hospital of Traditional Chinese Medicine

🇨🇳

Jinan, Shandong, China

Obstetrics and Gynecology Hospital of Fudan University

🇨🇳

Shanghai, Shanghai, China

Beijing Obstetrics and Gynecology Hospital,Capital Medical University

🇨🇳

Beijing, Beijing, China

Peking Union Medical College Hospital

🇨🇳

Beijing, Beijing, China

The First Hospital of Hunan University of chinese Medicine

🇨🇳

Changsha, Hunan, China

Shengjing Hospital of China Medical University

🇨🇳

Shen yang, Liaoning, China

Hubei Provincal Hospital of TCM

🇨🇳

Wuhan, Hubei, China

Guangxing Hospital Of Zhejiang Chinese Medicine University

🇨🇳

Hangzhou, Zhejiang, China

Peking University First Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath